Bracco Company Profile
✉ Email this page to a colleague
What is the competitive landscape for BRACCO, and what generic alternatives to BRACCO drugs are available?
BRACCO has forty approved drugs.
There are three US patents protecting BRACCO drugs.
There are thirty-seven patent family members on BRACCO drugs in twelve countries and seventy-four supplementary protection certificates in eight countries.
Drugs and US Patents for Bracco
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Bracco | RENO-DIP | diatrizoate meglumine | INJECTABLE;INJECTION | 010040-012 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Bracco | CHOLOGRAFIN SODIUM | iodipamide sodium | INJECTABLE;INJECTION | 009321-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Bracco | CHLORMERODRIN HG 197 | chlormerodrin hg-197 | INJECTABLE;INJECTION | 017269-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Bracco | VARIBAR THIN LIQUID | barium sulfate | FOR SUSPENSION;ORAL | 208036-004 | Apr 30, 2019 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Bracco | ROBENGATOPE | rose bengal sodium i-131 | INJECTABLE;INJECTION | 016224-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Bracco | ISOVUE-M 200 | iopamidol | INJECTABLE;INJECTION | 018735-001 | Dec 31, 1985 | AP1 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Bracco | GASTROGRAFIN | diatrizoate meglumine; diatrizoate sodium | SOLUTION;ORAL, RECTAL | 011245-003 | Approved Prior to Jan 1, 1982 | AA | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Bracco
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Bracco | PROHANCE | gadoteridol | INJECTABLE;INJECTION | 020131-001 | Nov 16, 1992 | 4,885,363 | ⤷ Try a Trial |
Bracco | KINEVAC | sincalide | INJECTABLE;INJECTION | 017697-001 | Approved Prior to Jan 1, 1982 | 6,803,046 | ⤷ Try a Trial |
Bracco | CARDIOTEC | technetium tc-99m teboroxime kit | INJECTABLE;INJECTION | 019928-001 | Dec 19, 1990 | 6,056,941 | ⤷ Try a Trial |
Bracco | CARDIOGEN-82 | rubidium chloride rb-82 | INJECTABLE;INJECTION | 019414-001 | Dec 29, 1989 | 4,562,829 | ⤷ Try a Trial |
Bracco | PROHANCE | gadoteridol | INJECTABLE;INJECTION | 020131-001 | Nov 16, 1992 | 5,474,756 | ⤷ Try a Trial |
Bracco | ISOVUE-250 | iopamidol | INJECTABLE;INJECTION | 020327-002 | Oct 12, 1994 | 4,001,323 | ⤷ Try a Trial |
Bracco | PROHANCE | gadoteridol | INJECTABLE;INJECTION | 020131-001 | Nov 16, 1992 | 6,143,274 | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for Bracco Drugs
Country | Patent Number | Estimated Expiration |
---|---|---|
South Korea | 102624471 | ⤷ Try a Trial |
World Intellectual Property Organization (WIPO) | 2020008031 | ⤷ Try a Trial |
South Africa | 202108096 | ⤷ Try a Trial |
European Patent Office | 3969065 | ⤷ Try a Trial |
China | 112165959 | ⤷ Try a Trial |
Japan | 7357078 | ⤷ Try a Trial |
South Korea | 20210029712 | ⤷ Try a Trial |
>Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Bracco Drugs
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
2822954 | 1890030-8 | Sweden | ⤷ Try a Trial | PRODUCT NAME: BICTEGRAVIR OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, IN PARTICULAR BICTEGRAVIR SODIUM; REG. NO/DATE: EU/1/18/1289 20180625 |
2203431 | 92666 | Luxembourg | ⤷ Try a Trial | PRODUCT NAME: DASABUVIR OU UN SEL QUI EN DERIVE, Y COMPRIS DASABUVIR SODIUMMONOHYDRATE. FIRST REGISTRATION: 20150119 |
0230893 | SPC/GB97/081 | United Kingdom | ⤷ Try a Trial | PRODUCT NAME: GADOBENATE DIMEGLUMINE; REGISTERED: UK 06099/0006 19970722 |
2203431 | 15C0013 | France | ⤷ Try a Trial | PRODUCT NAME: DASABUVIR OU UN SEL DE CELUI-CI, NOTAMMENT LE SEL DE SODIUM; REGISTRATION NO/DATE: EU/1/14/983 20150119 |
2666774 | LUC00167 | Luxembourg | ⤷ Try a Trial | PRODUCT NAME: RELEBACTAM, EVENTUELLEMENT SOUS FORME DE MONOHYDRATE, IMIPENEME ET CILASTATINE, EVENTUELLEMENT SOUS FORME DE SEL DE SODIUM; AUTHORISATION NUMBER AND DATE: EU/1/19/1420 20200217 |
1499331 | SPC/GB13/034 | United Kingdom | ⤷ Try a Trial | PRODUCT NAME: IZINOVA CONCENTRATE FOR ORAL SOLUTION. THE ACTIVE SUBSTANCE IS A MIXTURE OF 3 SALTS:SODIUM SULPHATE ANHYDROUS, MAGNESIUM SULPHATE HEPTAHYDRATE AND POTASSIUM SULPHATE.; REGISTERED: BE BE434323 20130220; UK PL34926/0016 20130313 |
3141251 | SPC/GB20/075 | United Kingdom | ⤷ Try a Trial | PRODUCT NAME: A MEDICINAL PRODUCT CONSISTING OF A COMBINATION OF A FIRST DOSE PHARMACEUTICAL COMPOSITION AND A SECOND DOSE PHARMACEUTICAL COMPOSITION, THE FIRST DOSE PHARMACEUTICAL COMPOSITION CONSISTING OF THE ACTIVE INGREDIENTS: POLYETHYLENE GLYCOL 3350, SODIUM SULPH; REGISTERED: IS IS/1/17/063/01 20171016; UK PL 20011/0040 20171016 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Here is a list of applicants with similar names.